These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 26708110)

  • 1. Inhibitory effect of phenothiazine- and phenoxazine-derived chloroacetamides on Leishmania major growth and Trypanosoma brucei trypanothione reductase.
    Marcu A; Schurigt U; Müller K; Moll H; Krauth-Siegel RL; Prinz H
    Eur J Med Chem; 2016 Jan; 108():436-443. PubMed ID: 26708110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenothiazine inhibitors of trypanothione reductase as potential antitrypanosomal and antileishmanial drugs.
    Chan C; Yin H; Garforth J; McKie JH; Jaouhari R; Speers P; Douglas KT; Rock PJ; Yardley V; Croft SL; Fairlamb AH
    J Med Chem; 1998 Jan; 41(2):148-56. PubMed ID: 9457238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation of 9,9-dimethylxanthene tricyclics against trypanothione reductase, Trypanosoma brucei, Trypanosoma cruzi and Leishmania donovani.
    Chibale K; Visser M; Yardley V; Croft SL; Fairlamb AH
    Bioorg Med Chem Lett; 2000 Jun; 10(11):1147-50. PubMed ID: 10866368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metal-based compounds as prospective antileishmanial agents: inhibition of trypanothione reductase by selected gold complexes.
    Colotti G; Ilari A; Fiorillo A; Baiocco P; Cinellu MA; Maiore L; Scaletti F; Gabbiani C; Messori L
    ChemMedChem; 2013 Oct; 8(10):1634-7. PubMed ID: 24039168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of an additional hydrophobic binding site, the Z site, in the rational drug design of a new class of stronger trypanothione reductase inhibitor, quaternary alkylammonium phenothiazines.
    Khan MO; Austin SE; Chan C; Yin H; Marks D; Vaghjiani SN; Kendrick H; Yardley V; Croft SL; Douglas KT
    J Med Chem; 2000 Aug; 43(16):3148-56. PubMed ID: 10956223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of chalcone-based antileishmanial agents targeting trypanothione reductase.
    Ortalli M; Ilari A; Colotti G; De Ionna I; Battista T; Bisi A; Gobbi S; Rampa A; Di Martino RMC; Gentilomi GA; Varani S; Belluti F
    Eur J Med Chem; 2018 May; 152():527-541. PubMed ID: 29758517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and in vitro antiprotozoal activities of 5-phenyliminobenzo[a]phenoxazine derivatives.
    Shi XL; Ge JF; Liu BQ; Kaiser M; Wittlin S; Brun R; Ihara M
    Bioorg Med Chem Lett; 2011 Oct; 21(19):5804-7. PubMed ID: 21868222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and in vitro antikinetoplastid activity of polyamine-hydroxybenzotriazole conjugates.
    Jagu E; Pomel S; Diez-Martinez A; Ramiandrasoa F; Krauth-Siegel RL; Pethe S; Blonski C; Labruère R; Loiseau PM
    Bioorg Med Chem; 2017 Jan; 25(1):84-90. PubMed ID: 27793448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First example of peptides targeting the dimer interface of Leishmania infantum trypanothione reductase with potent in vitro antileishmanial activity
    Ruiz-Santaquiteria M; Sánchez-Murcia PA; Toro MA; de Lucio H; Gutiérrez KJ; de Castro S; Carneiro FAC; Gago F; Jiménez-Ruiz A; Camarasa MJ; Velázquez S
    Eur J Med Chem; 2017 Jul; 135():49-59. PubMed ID: 28431354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel 3-chloro-6-nitro-1
    Mohamed Abdelahi MM; El Bakri Y; Lai CH; Subramani K; Anouar EH; Ahmad S; Benchidmi M; Mague JT; Popović-Djordjević J; Goumri-Said S
    J Enzyme Inhib Med Chem; 2022 Dec; 37(1):151-167. PubMed ID: 34894940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Inactivation of Trypanosoma cruzi trypanothione reductase by phenothiazine cationic free radicals].
    Gutierrez Correa J; Fairlamb AH; Stoppani AO
    Rev Argent Microbiol; 2001; 33(1):36-46. PubMed ID: 11407019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel alkylpolyaminoguanidines and alkylpolyaminobiguanides with potent antitrypanosomal activity.
    Bi X; Lopez C; Bacchi CJ; Rattendi D; Woster PM
    Bioorg Med Chem Lett; 2006 Jun; 16(12):3229-32. PubMed ID: 16616495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tulbaghia violacea and Allium ursinum Extracts Exhibit Anti-Parasitic and Antimicrobial Activities.
    Krstin S; Sobeh M; Braun MS; Wink M
    Molecules; 2018 Feb; 23(2):. PubMed ID: 29393867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Leishmania infantum trypanothione reductase by azole-based compounds: a comparative analysis with its physiological substrate by X-ray crystallography.
    Baiocco P; Poce G; Alfonso S; Cocozza M; Porretta GC; Colotti G; Biava M; Moraca F; Botta M; Yardley V; Fiorillo A; Lantella A; Malatesta F; Ilari A
    ChemMedChem; 2013 Jul; 8(7):1175-83. PubMed ID: 23733388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding to large enzyme pockets: small-molecule inhibitors of trypanothione reductase.
    Persch E; Bryson S; Todoroff NK; Eberle C; Thelemann J; Dirdjaja N; Kaiser M; Weber M; Derbani H; Brun R; Schneider G; Pai EF; Krauth-Siegel RL; Diederich F
    ChemMedChem; 2014 Aug; 9(8):1880-91. PubMed ID: 24788386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rationally designed selective inhibitors of trypanothione reductase. Phenothiazines and related tricyclics as lead structures.
    Benson TJ; McKie JH; Garforth J; Borges A; Fairlamb AH; Douglas KT
    Biochem J; 1992 Aug; 286 ( Pt 1)(Pt 1):9-11. PubMed ID: 1355650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In silico identification and evaluation of new Trypanosoma cruzi trypanothione reductase (TcTR) inhibitors obtained from natural products database of the Bahia semi-arid region (NatProDB).
    da Paixão VG; Pita SSDR
    Comput Biol Chem; 2019 Apr; 79():36-47. PubMed ID: 30710804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyridazino-pyrrolo-quinoxalinium salts as highly potent and selective leishmanicidal agents targeting trypanothione reductase.
    de Lucio H; García-Marín J; Sánchez-Alonso P; García-Soriano JC; Toro MÁ; Vaquero JJ; Gago F; Alajarín R; Jiménez-Ruiz A
    Eur J Med Chem; 2022 Jan; 227():113915. PubMed ID: 34695777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, and in vitro biological evaluation of novel thiazolopyrimidine derivatives as antileishmanial compounds.
    Istanbullu H; Bayraktar G; Akbaba H; Cavus I; Coban G; Debelec Butuner B; Kilimcioglu AA; Ozbilgin A; Alptuzun V; Erciyas E
    Arch Pharm (Weinheim); 2020 Aug; 353(8):e1900325. PubMed ID: 32484266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and antiprotozoal activity of some new synthetic substituted quinoxalines.
    Hui X; Desrivot J; Bories C; Loiseau PM; Franck X; Hocquemiller R; Figadère B
    Bioorg Med Chem Lett; 2006 Feb; 16(4):815-20. PubMed ID: 16309903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.